Literature DB >> 7688311

Induction of macrophage nitric oxide production by interferon-gamma and tumor necrosis factor-alpha is enhanced by interleukin-10.

S B Corradin1, N Fasel, Y Buchmüller-Rouiller, A Ransijn, J Smith, J Mauël.   

Abstract

Interleukin-10 (IL-10) has been reported to inhibit nitric oxide (NO) synthesis and microbicidal activity of interferon-gamma (IFN-gamma)-stimulated macrophages (M phi) by preventing the secretion of tumor necrosis factor-alpha (TNF-alpha) which serves as an autocrine activating signal. We have examined the effects of recombinant IL-10 on the capacity of IFN-gamma together with exogenous TNF-alpha to induce NO synthesis by bone marrow-derived M phi. Under these conditions and in contrast to its reported deactivating potential, IL-10 strongly enhanced NO synthesis measured as nitrite (NO2-) release (half maximal stimulation at approximately 10 U/ml). IL-10 further increased NO2- production by M phi stimulated in the presence of optimal concentrations of prostaglandin E2, a positive modulator of M phi activation by IFN-gamma/TNF-alpha. Increased steady state levels of NO synthase mRNA were observed in 4-h IFN-gamma/TNF-alpha cultures and enhanced NO2(-)-release was evident 24 h but not 48 h after stimulation. These results suggest that the effects of IL-10 on M phi function are more complex than previously recognized.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688311     DOI: 10.1002/eji.1830230851

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Effect of enforced expression of human bcl-2 on Japanese encephalitis virus-induced apoptosis in cultured cells.

Authors:  C L Liao; Y L Lin; J J Wang; Y L Huang; C T Yeh; S H Ma; L K Chen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Inhibition of Japanese encephalitis virus infection by nitric oxide: antiviral effect of nitric oxide on RNA virus replication.

Authors:  Y L Lin; Y L Huang; S H Ma; C T Yeh; S Y Chiou; L K Chen; C L Liao
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

3.  An in vitro model for infection with Leishmania major that mimics the immune response in mice.

Authors:  M B Soares; J R David; R G Titus
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

4.  HIF-1alpha expression regulates the bactericidal capacity of phagocytes.

Authors:  Carole Peyssonnaux; Vivekanand Datta; Thorsten Cramer; Andrew Doedens; Emmanuel A Theodorakis; Richard L Gallo; Nancy Hurtado-Ziola; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

5.  Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection.

Authors:  E L Oleszak; C D Katsetos; J Kuzmak; A Varadhachary
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

6.  Free radical activity and pro-inflammatory effects of particulate air pollution (PM10) in vivo and in vitro.

Authors:  X Y Li; P S Gilmour; K Donaldson; W MacNee
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

7.  Neurodegeneration and glia response in rat hippocampus following nitro-L-arginine methyl ester (L-NAME).

Authors:  G J Harry; R Sills; M J Schlosser; W E Maier
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

Review 8.  Theiler's virus infection: a model for multiple sclerosis.

Authors:  Emilia L Oleszak; J Robert Chang; Herman Friedman; Christos D Katsetos; Chris D Platsoucas
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Effect of interleukin-4 and interleukin-10 on leucocyte migration and nitric oxide production in the mouse.

Authors:  M Perretti; C Szabó; C Thiemermann
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

10.  IL-10 up-regulates nitric oxide (NO) synthesis by lipopolysaccharide (LPS)-activated macrophages: improved control of Trypanosoma cruzi infection.

Authors:  F Jacobs; D Chaussabel; C Truyens; V Leclerq; Y Carlier; M Goldman; B Vray
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.